These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 12687010

  • 1. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.
    Stoica GE, Franke TF, Wellstein A, Morgan E, Czubayko F, List HJ, Reiter R, Martin MB, Stoica A.
    Oncogene; 2003 Apr 10; 22(14):2073-87. PubMed ID: 12687010
    [Abstract] [Full Text] [Related]

  • 2. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
    Stoica GE, Franke TF, Moroni M, Mueller S, Morgan E, Iann MC, Winder AD, Reiter R, Wellstein A, Martin MB, Stoica A.
    Oncogene; 2003 Sep 11; 22(39):7998-8011. PubMed ID: 12970748
    [Abstract] [Full Text] [Related]

  • 3. Estradiol rapidly activates Akt via the ErbB2 signaling pathway.
    Stoica GE, Franke TF, Wellstein A, Czubayko F, List HJ, Reiter R, Morgan E, Martin MB, Stoica A.
    Mol Endocrinol; 2003 May 11; 17(5):818-30. PubMed ID: 12554767
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase.
    Tan M, Grijalva R, Yu D.
    Cancer Res; 1999 Apr 01; 59(7):1620-5. PubMed ID: 10197638
    [Abstract] [Full Text] [Related]

  • 6. Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.
    Söderlund K, Pérez-Tenorio G, Stål O.
    Int J Oncol; 2005 Jan 01; 26(1):25-32. PubMed ID: 15586221
    [Abstract] [Full Text] [Related]

  • 7. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H, Akita RW, Sliwkowski MX, Maihle NJ.
    Cancer Res; 2001 Jun 01; 61(11):4467-73. PubMed ID: 11389077
    [Abstract] [Full Text] [Related]

  • 8. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 9. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 10. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I.
    Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A.
    Endocrinology; 2000 Dec 01; 141(12):4503-11. PubMed ID: 11108261
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.
    Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE, Yu D.
    Cancer Res; 2001 Feb 15; 61(4):1727-32. PubMed ID: 11245489
    [Abstract] [Full Text] [Related]

  • 12. A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.
    Hatakeyama M, Kimura S, Naka T, Kawasaki T, Yumoto N, Ichikawa M, Kim JH, Saito K, Saeki M, Shirouzu M, Yokoyama S, Konagaya A.
    Biochem J; 2003 Jul 15; 373(Pt 2):451-63. PubMed ID: 12691603
    [Abstract] [Full Text] [Related]

  • 13. Neuregulin signaling through a PI3K/Akt/Bad pathway in Schwann cell survival.
    Li Y, Tennekoon GI, Birnbaum M, Marchionni MA, Rutkowski JL.
    Mol Cell Neurosci; 2001 Apr 15; 17(4):761-7. PubMed ID: 11312610
    [Abstract] [Full Text] [Related]

  • 14. Heregulin-induced VEGF expression via the ErbB3 signaling pathway in colon cancer.
    Yonezawa M, Wada K, Tatsuguchi A, Akamatsu T, Gudis K, Seo T, Mitsui K, Nagata K, Tanaka S, Fujimori S, Sakamoto C.
    Digestion; 2009 Apr 15; 80(4):215-25. PubMed ID: 19797898
    [Abstract] [Full Text] [Related]

  • 15. Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells.
    Lim SJ, Lopez-Berestein G, Hung MC, Lupu R, Tari AM.
    Oncogene; 2000 Dec 14; 19(54):6271-6. PubMed ID: 11175341
    [Abstract] [Full Text] [Related]

  • 16. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
    St-Laurent V, Sanchez M, Charbonneau C, Tremblay A.
    J Steroid Biochem Mol Biol; 2005 Feb 14; 94(1-3):23-37. PubMed ID: 15862947
    [Abstract] [Full Text] [Related]

  • 17. Pentagalloylglucose inhibits estrogen receptor alpha by lysosome-dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF-7 cells.
    Hua KT, Way TD, Lin JK.
    Mol Carcinog; 2006 Aug 14; 45(8):551-60. PubMed ID: 16637063
    [Abstract] [Full Text] [Related]

  • 18. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression.
    Sun Y, Lin H, Zhu Y, Ma C, Ye J, Luo J.
    J Cell Physiol; 2002 Aug 14; 192(2):225-33. PubMed ID: 12115729
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of the Csk homologous kinase facilitates phosphorylation of Akt/PKB in MCF-7 cells.
    Zagozdzon R, Bougeret C, Fu Y, Avraham HK.
    Int J Oncol; 2002 Dec 14; 21(6):1347-52. PubMed ID: 12429987
    [Abstract] [Full Text] [Related]

  • 20. Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.
    Altiok N, Altiok S, Changeux JP.
    EMBO J; 1997 Feb 17; 16(4):717-25. PubMed ID: 9049301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.